Products for Research Use Only
RegisterLogin

CDK9-IN-44

CAT: 0804-HY-178499Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-178499Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CDK9-IN-44 (Compound 7) is a selective CDK9 inhibitor (IC50=7.6 μM) . CDK9-IN-44 inhibits CDK9/cyclin T1 kinase activity, blocking transcriptional elongation, reducing the expression of pro-cancer proteins (such as MCL1, c-MYC), and inducing tumor cell apoptosis. CDK9-IN-44 is promising for research of glioblastoma (GBM) and central nervous system (CNS) disorders[1].
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer; Neurological Disease
Smiles
OC1=CC=C(C2=COC3=C([C@H]([C@H]4CCCO4)CC(O5)=O)C5=CC(O)=C3C2=O)C=C1
Molecular Formula
C22H18O7
Molecular Weight
394.37
References & Citations
[1]Khan Z R, et al. Computationally Motivated Discovery of Biogenic Compounds with Potent CDK9 Inhibition and In Vitro Effects against Glioblastoma[J]. ACS Chemical Neuroscience, 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK9

Related Products

CatalogName
HY-173310CDK2-IN-44
HY-143585-01CDK9-IN-14
HY-179023CDK9-IN-45
HY-176736CDK9-IN-40
HY-173481CDK9-IN-37
HY-157980CDK9-IN-32
HY-155153CDK9-IN-24
HY-160171CDK9-IN-31
HY-115714-01CDK9-IN-12
HY-130852-01CDK9-IN-11

Alternative Products

CatalogName
GTR19273317-01CDK9-IN-44
030081CDK9
JH1809444'44'
GTR18308618CDK9-55/CDK9 Rabbit Polyclonal Antibody
GTR18187313CDK9 Antibody
BA3838-50CDK9-IN-10
BA3826-1CDK9-IN-13
BA2986-1CDK9-IN-7
BA3853-10CDK9-IN-14
T205526-01CDK9-IN-36

Popular Products